CH618429A5 - - Google Patents

Download PDF

Info

Publication number
CH618429A5
CH618429A5 CH1644375A CH1644375A CH618429A5 CH 618429 A5 CH618429 A5 CH 618429A5 CH 1644375 A CH1644375 A CH 1644375A CH 1644375 A CH1644375 A CH 1644375A CH 618429 A5 CH618429 A5 CH 618429A5
Authority
CH
Switzerland
Prior art keywords
group
tert
butyl
formula
atoms
Prior art date
Application number
CH1644375A
Other languages
German (de)
English (en)
Inventor
Hans Jorgen Petersen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of CH618429A5 publication Critical patent/CH618429A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
CH1644375A 1974-12-20 1975-12-18 CH618429A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB55209/74A GB1489879A (en) 1974-12-20 1974-12-20 N'-cyano-n'-3-pyridylguanidines

Publications (1)

Publication Number Publication Date
CH618429A5 true CH618429A5 (fr) 1980-07-31

Family

ID=10473276

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1644375A CH618429A5 (fr) 1974-12-20 1975-12-18

Country Status (22)

Country Link
US (2) US4057636A (fr)
JP (1) JPS6028819B2 (fr)
AT (1) AT346357B (fr)
BE (1) BE836885A (fr)
CA (1) CA1067083A (fr)
CH (1) CH618429A5 (fr)
DD (1) DD122529A5 (fr)
DE (2) DE2560633C2 (fr)
DK (1) DK145341C (fr)
ES (1) ES443725A1 (fr)
FI (1) FI60560C (fr)
FR (1) FR2294703A1 (fr)
GB (1) GB1489879A (fr)
IE (1) IE42141B1 (fr)
IT (1) IT1062213B (fr)
LU (1) LU74071A1 (fr)
NL (1) NL184109C (fr)
PH (1) PH12506A (fr)
SE (1) SE424637B (fr)
SU (1) SU683615A3 (fr)
YU (1) YU39754B (fr)
ZA (1) ZA757481B (fr)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5562066A (en) * 1978-11-03 1980-05-10 Toshihiko Okamoto N-(2-substituted-4-pyridyl)-urea and thio urea, their preparation and plant growth regulator
US4490533A (en) * 1980-12-22 1984-12-25 Merck & Co., Inc. Aminoalkyl pyridine derivatives
IE52935B1 (en) * 1981-04-15 1988-04-13 Leo Pharm Prod Ltd Pharmaceutical preparation
IE54196B1 (en) * 1981-09-10 1989-07-19 Leo Pharm Prod Ltd Chemical compounds
DK58983D0 (da) * 1983-02-11 1983-02-11 Leo Pharm Prod Ltd Farmaceutisk praeparat
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
US4617311A (en) * 1985-05-17 1986-10-14 Eli Lilly And Company Antiasthmatic method
DE3887591T2 (de) * 1987-07-07 1994-05-19 Beecham Group Plc Pinacidil zur Behandlung von pulmonaler Hypertonie oder Rechtsversagen.
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation
US5244664A (en) * 1988-01-21 1993-09-14 Leo Pharmaceutical Products Ltd. Topical preparation for treatment of alopecia
GB8801318D0 (en) * 1988-01-21 1988-02-17 Leo Pharm Prod Ltd Pharmaceutical preparations
WO1989010757A1 (fr) * 1988-05-10 1989-11-16 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemis Nouvelle preparation ophtalmique pour le traitement de glaucomes
US5011837A (en) * 1988-08-09 1991-04-30 E. R. Squibb & Sons, Inc. Aryl cyanoguanidines: potassium channel activators and method of making same
NZ229828A (en) * 1988-08-09 1992-03-26 Squibb & Sons Inc Aryl cyanoguanidine derivatives and pharmaceutical compositions
US5278169A (en) * 1988-08-09 1994-01-11 E. R. Squibb & Sons, Inc. Method of treating or prevention of fibrillation of the heart
JP2884412B2 (ja) * 1988-10-21 1999-04-19 日本バイエルアグロケム株式会社 殺虫性シアノ化合物
AU623217B2 (en) * 1989-02-03 1992-05-07 Eli Lilly And Company (-)-n"-cyano-n-3-pyridyl-n'-1,2,2-trimethyl- propylguanidine, a process for preparing the compound, and use of the compound as a medicament
US5264445A (en) * 1989-02-03 1993-11-23 Eli Lilly And Company (-)-N"-cyano-N-3-pyridyl-N'-1,2,2-trimethylpropylguanidine
EP0407346A3 (en) * 1989-07-07 1991-10-02 Ciba-Geigy Ag Aminopyridines
US5006523A (en) * 1989-10-26 1991-04-09 E. R. Squibb & Sons, Inc. Antiarrhythmic agents: aryl cyanoguanidine potassium channel blockers
US5217982A (en) * 1990-09-25 1993-06-08 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive properties
JPH05294935A (ja) * 1991-03-15 1993-11-09 Green Cross Corp:The アミノピリジン系化合物
US5371086A (en) * 1991-03-15 1994-12-06 The Green Cross Corporation Aminopyridine compounds
FR2677019B1 (fr) * 1991-05-27 1994-11-25 Pf Medicament Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique.
US5593993A (en) * 1991-08-02 1997-01-14 Medivir Ab Method for inhibition of HIV related viruses
IL102548A (en) * 1991-08-02 1998-08-16 Medivir Ab Use of painting derivatives in the preparation of drugs for VIH inhibition and treatment of SDIA and new compounds
CA2123312A1 (fr) * 1991-12-23 1993-07-08 Pharmacia & Upjohn Company Medicament efficace pour le traitement des dysfonctions erectiles
US5262419A (en) * 1992-06-11 1993-11-16 E. R. Squibb & Sons, Inc. Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
AU4530693A (en) * 1992-08-13 1994-03-15 Upjohn Company, The Cyanoguanidines as potassium channel blockers
GB9219472D0 (en) * 1992-09-15 1992-10-28 Leo Pharm Prod Ltd Chemical compounds
JPH06228100A (ja) * 1992-12-07 1994-08-16 Green Cross Corp:The 光学活性アミノピリジン誘導体およびその用途
EP0703904B1 (fr) * 1993-06-11 1999-02-24 PHARMACIA & UPJOHN COMPANY Cyanoguanidines au pyrimidine utilisees en tant qu'agents bloquant des vannes a potassium
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
US5633374A (en) * 1993-11-26 1997-05-27 The Upjohn Company Pyrimidine, cyanoguanidines as K-channel blockers
MX9603051A (es) * 1994-01-28 1997-06-28 Upjohn Co Cianoguanidinas como bloqueadores del canal-k.
US5525742A (en) * 1994-06-10 1996-06-11 The Upjohn Company Azidophenylcyanoguanidines as photoaffinity probes
US5856449A (en) * 1994-11-17 1999-01-05 Pharmacia & Upjohn Company Protein affecting KATP channels
WO1998006399A1 (fr) * 1996-08-15 1998-02-19 Smithkline Beecham Corporation Antagonistes du recepteur d'il-8
US5972894A (en) * 1997-08-07 1999-10-26 Cytran, Inc. Peptides having potassium channel opener activity
US6458835B2 (en) 1997-08-13 2002-10-01 Bristol-Myers Squibb Company Method of inhibiting or treating chemotherapy-induced hair loss
US6013668A (en) * 1997-08-13 2000-01-11 Bristol-Myers Squibb Company Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl) amino]methyl]amino]benzonitrile
AU9211098A (en) * 1997-09-03 1999-03-22 American Home Products Corporation Thiourea for increasing hdl-cholesterol levels, which are useful as anti-atherosclerotic agents
WO2000061561A1 (fr) 1999-04-09 2000-10-19 Shionogi Bioresearch Corp. Composes a base de cyanoguanidine
GB9908410D0 (en) 1999-04-13 1999-06-09 Pfizer Ltd Pyridines
US6417207B1 (en) 1999-05-12 2002-07-09 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
US6645968B2 (en) 1999-08-03 2003-11-11 Abbott Laboratories Potassium channel openers
US7589112B2 (en) * 2002-10-24 2009-09-15 Merck Patent Gmbh Methylene urea derivatives
EP1917244A2 (fr) * 2005-08-24 2008-05-07 Abbott GmbH & Co. KG Composes guanidine a substitution hetaryl et utilisation en tant que partenaires de liaison pour des recepteurs de 5-ht5
US20070250567A1 (en) * 2006-04-20 2007-10-25 Graham Philip R System and method for controlling a telepresence system
WO2009089053A1 (fr) * 2008-01-11 2009-07-16 Nektar Therapeutics Al, Corporation Conjugués de la classe des guanidines-oligomères
DK2649048T3 (en) * 2010-12-09 2016-07-25 Radikal Therapeutics Inc MULTIFUNCTIONAL NITROXIDE DERIVATIVES AND USE THEREOF
US20220324809A1 (en) * 2019-09-03 2022-10-13 Salzman Group Ltd. Atp-regulated potassium channel openers and uses thereof
WO2023176554A1 (fr) * 2022-03-14 2023-09-21 国立大学法人東北大学 Agent améliorant la fonction cognitive

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3036083A (en) * 1959-05-15 1962-05-22 Ciba Geigy Corp Certain 2-pyridyl lower alkyl guanidines
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines

Also Published As

Publication number Publication date
YU316275A (en) 1982-02-28
YU39754B (en) 1985-04-30
ES443725A1 (es) 1977-04-16
JPS6028819B2 (ja) 1985-07-06
DE2557438C2 (fr) 1989-01-05
DE2557438A1 (de) 1976-06-24
FR2294703B1 (fr) 1980-06-27
DE2560633C2 (fr) 1988-09-08
FI60560C (fi) 1982-02-10
ATA936075A (de) 1978-03-15
AT346357B (de) 1978-11-10
DK145341B (da) 1982-11-01
US4057636A (en) 1977-11-08
DK145341C (da) 1983-03-28
IT1062213B (it) 1983-09-20
FI753520A (fr) 1976-06-21
BE836885A (fr) 1976-06-21
NL7514852A (nl) 1976-06-22
JPS5186474A (fr) 1976-07-29
SE424637B (sv) 1982-08-02
AU8712775A (en) 1977-06-09
LU74071A1 (fr) 1976-11-11
PH12506A (en) 1979-04-18
NL184109C (nl) 1989-04-17
CA1067083A (fr) 1979-11-27
IE42141B1 (en) 1980-06-04
FI60560B (fi) 1981-10-30
GB1489879A (en) 1977-10-26
DD122529A5 (fr) 1976-10-12
IE42141L (en) 1976-06-20
NL184109B (nl) 1988-11-16
DK572975A (da) 1976-06-21
USRE31244E (en) 1983-05-17
SE7514153L (sv) 1976-06-21
ZA757481B (en) 1977-01-26
FR2294703A1 (fr) 1976-07-16
SU683615A3 (ru) 1979-08-30

Similar Documents

Publication Publication Date Title
CH618429A5 (fr)
EP0242851B1 (fr) Dérivés du N-(2'-aminophényl)-benzamide, procédé pour leur fabrication et leur utilisation dans la lutte contre les maladies néoplastiques
DE2012138C3 (de) N{4-(ß-Pyrazin- 2-carboxyamido-äthyl)benzolsulphonyl] -N' - cycloalkylharnstoffe und diese enthaltende pharmazeutische Präparate
EP0104423B1 (fr) Nitro-2-éthènediamines-1,1, procédé pour leur préparation ainsi que leur application comme médicaments
DE2847792C2 (fr)
DE2461802C2 (de) Pyrazincarboxamidderivate
DE1493672C3 (de) Verfahren zur Herstellung von Benzolsulfonylharnstoffen
DE2238870C3 (de) Benzolsulfonylharnstoffe
DE2526795A1 (de) Sulfonamide
DE1443911B2 (de) Benzolsulfonylharnstoffe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE2450161C3 (de) N-ß-(3',4'-Dihydroxyphenäthyl)- glutamin und dessen Alkylester sowie deren pharmakologisch verträgliche Säureadditionssalze, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
EP0030343A1 (fr) Amino-2 dihydro-3,4-pyridines substituées, procédé pour leur préparation et utilisation comme médicaments
DE1518816B2 (de) Benzolsulfony!harnstoffe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE2629756C2 (fr)
AT390790B (de) Verfahren zur herstellung des neuen 3-amino-4-(2-((2-guanidinothiazol-4-yl)methylth o)-ethylamino)-1,2,5-thiadiazols
AT238215B (de) Verfahren zur Herstellung von neuen Benzolsulfonylharnstoffen
DE3107599C2 (de) N-Cyan-N'-methyl-N"-{2-[(5-methylthio-imidazol-4-yl)-methylthio]-äthyl}-guanidin, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Arzneimittel
DE3233380A1 (de) Substituierte pyridyl-cyanoguanidinverbindungen
DE1251753B (de) Verfahren zur Herstellung von Benzolsulfonylharnstoffen
DE1593924B2 (de) 6-Guanidomethyl-1,4-benzodlOxan und dessen pharmakologisch nichtgiftige Säureadditionssalze sowie Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2948522A1 (de) Benzolsulfonylharnstoffe und verfahren zu ihrer herstellung
AT236397B (de) Verfahren zur Herstellung von neuen Azidobenzolsulfonylharnstoffen
DE1670059A1 (de) Guanidinderivate und Verfahren zu ihrer Herstellung
DE1695565A1 (de) Neuartige Piperidinderivate und Verfahren zu ihrer Herstellung
CH647236A5 (de) N-aryl-n'-(2-imidazolidinyliden)-harnstoffe sowie arzneimittel zur behandlung von hypertonie und intestinalen stoerungen.

Legal Events

Date Code Title Description
PL Patent ceased